Who is sponsoring NCT03819504?

NCT03819504 is sponsored by University Hospital Ostrava.

What drugs are being tested in NCT03819504?

Interventions in NCT03819504: 4-D navigated stereotactic radio surgical ablation.

What condition does NCT03819504 study?

NCT03819504 studies Ventricular Tachycardia.

Is NCT03819504 still recruiting?

NCT03819504 is currently withdrawn. Last updated 19 October 2020.

Last reviewed 2020-10-19 · How we verify

NCT03819504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stereotactic Non-invasive Ablation of Ventricular Tachycardia

Withdrawn NA Last updated 19 October 2020

What this trial tests

NA trial testing 4-D navigated stereotactic radio surgical ablation in Ventricular Tachycardia. Withdrawn.

Timeline

1 August 2018

Primary endpoint
30 September 2020

30 September 2020

Quick facts

Lead sponsor	University Hospital Ostrava
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 August 2018
Primary completion	30 September 2020
Estimated completion	30 September 2020
Sites	3 locations across Czechia

Drugs / interventions tested

4-D navigated stereotactic radio surgical ablation

Conditions studied

Ventricular Tachycardia — all drugs for Ventricular Tachycardia →

Sponsor

University Hospital Ostrava

Who can join

30 and older, any sex, with Ventricular Tachycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

STereotactic Ablative Radiosurgery of recurrent Ventricular Tachycardia in structural heart disease (STAR-VT).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA).
Blanck O, Buergy D, Vens M, Eidinger L, et al · · 2020 · cited 55× · PMID 32306083 · DOI 10.1007/s00392-020-01650-9
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions.
Jumeau R, Ozsahin M, Schwitter J, Elicin O, et al · · 2020 · cited 30× · PMID 32671101 · DOI 10.3389/fcvm.2020.00108
Clinical Evidence behind Stereotactic Radiotherapy for the Treatment of Ventricular Tachycardia (STAR)-A Comprehensive Review.
Miszczyk M, Jadczyk T, Gołba K, Wojakowski W, et al · · 2021 · cited 23× · PMID 33802802 · DOI 10.3390/jcm10061238
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia): rationale and design of an Italian experimental prospective study.
Carbucicchio C, Jereczek-Fossa BA, Andreini D, Catto V, et al · · 2021 · cited 16× · PMID 32851578 · DOI 10.1007/s10840-020-00855-2

Verify or expand the search:

Other recruiting trials for Ventricular Tachycardia

Currently open trials in the same condition.

NCT07201506 — Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation · NA · recruiting
NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
NCT07116525 — A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter · NA · recruiting
NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting
NCT06592001 — Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study · NA · active not recruiting

Other University Hospital Ostrava trials

Trials by the same sponsor.

NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07041086 — Prehospital ECPR in Moravia Silesia Region · recruiting
NCT07009652 — Optimization of Transport and Use of a Mobile ECMO Team in Patients With Sudden Cardiac Arrest in the Moravian-Silesian · recruiting
NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03819504 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Ostrava
Last refreshed: 19 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing